Bayer Aktiengesellschaft (VIE:BAYN)
Austria
· Delayed Price · Currency is EUR 33.34
-0.21 (-0.63%)
At close: Dec 5, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Crop Science Revenue | 21.61B | 22.26B |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Revenue | 18.01B | 18.13B |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Health Revenue | 5.91B | 5.87B |
Log In |
Log In |
Log In | Upgrade
|
| All Other Segment Revenue | - | 327.00M |
Log In |
Log In |
Log In | Upgrade
|
| Enabling Functions and Consolidation Revenue | - | 19.00M |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Europe/Middle East/Africa Revenue | 13.60B | 13.98B |
Log In |
Log In |
Log In | Upgrade
|
| North America Revenue | 16.67B | 16.48B |
Log In |
Log In |
Log In | Upgrade
|
| Asia/Pacific Revenue | 7.89B | 8.07B |
Log In |
Log In |
Log In | Upgrade
|
| Latin America Revenue | 7.71B | 8.08B |
Log In |
Log In |
Log In | Upgrade
|
Adjusted EBITDA
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Crop Science Adjusted EBITDA | 4.34B | 4.33B |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Adjusted EBITDA | 4.59B | 4.72B |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Health Adjusted EBITDA | 1.40B | 1.37B |
Log In |
Log In |
Log In | Upgrade
|
| All Other Segment Adjusted EBITDA | - | 62.00M |
Log In |
Log In |
Log In | Upgrade
|
| Enabling Functions and Consolidation Adjusted EBITDA | - | -352.00M |
Log In |
Log In |
Log In | Upgrade
|